Report : Global Penile Implants Market 2016-2020 is a new market research publication announced by Reportstack.
Report Outline: ED is typically caused by various conditions including congenital anomalies, iatrogenesis, vascular conditions (including cardiovascular disease, diabetes, and high blood pressure), Peyronie's disease, penile or pelvic trauma, and complications in treating prostate cancer. Penile implants, or penile prosthesis, are a method of treating ED. These devices are implanted in the corpora cavernosa of the penis through a surgical procedure. Penile implants are considered to be the most effective treatment for ED. These implants are generally considered when less intrusive therapeutic medicines, like oral pharmaceuticals (PDE5 inhibitors: Viagra, Levitra, Cialis), penile infusions, or vacuum erection devices are unsuccessful, give an unsatisfactory result, or are contraindicated.
The penile implants currently offered in the market are categorized into semi-rigid/malleable (bendable) rod penile implants and inflatable penile implants. A penile implant helps enhance a man's psychological and emotional well-being as well as restore sexual satisfaction.
For detailed report with TOC, please click here Global Penile Implants Market 2016-2020.
Market Growth: The global penile implants market is expected to grow at a CAGR of 1.58% during the period 2016-2020.
• American Medical Systems
• Zephyr Surgical Implants (ZSI)
Other prominent vendors
• HR Penile Prosthesis
• Silimed Malleable Implant
• Jonas (ESKA) Prosthesis
• Virilis I Implant and Virilis II Implant
• Apollo implant
American Medical Systems, Zephyr Surgical Implants (ZSI), Promedon, Coloplast, Shah, HR Penile Prosthesis, Silimed Malleable Implant, Jonas (ESKA) Prosthesis, Virilis I Implant and Virilis II Implant, Apollo implant.
Manager - Marketing
Reportstack Market Research